Ulrike Bode
Hochschule Hannover
20 Papers
219 Citations
Ulrike Bode is an academic researcher from Hochschule Hannover. The author has contributed to research in topics: Cytotoxic T cell & T cell. The author has an hindex of 15, co-authored 20 publications.
Chat about Author
Papers
Long-term outcome of hepatitis C virus infection after liver transplantation
Klaus H.W. Böker,G. Dalley,Matthias J. Bahr,H. Maschek,Hans L. Tillmann,Christian Trautwein,K. Oldhaver,Ulrike Bode,Rudolf Pichlmayr,Michael P. Manns +9 more
TL;DR: Chronic hepatitis develops in the majority of patients with HCV infection after liver transplantation, and the disease course closely resembles that seen in nontransplanted hepatitis C patients.
233
Famciclovir treatment of hepatitis B virus recurrence after liver transplantation: A pilot study
M. Krüger,Hans L. Tillmann,Christian Trautwein,Ulrike Bode,Karl J. Oldhafer,H. Maschek,Klaus H.W. Böker,Christoph E. Broelsch,Rudolf Pichlmayr,Michael P. Manns +9 more
TL;DR: The oral nucleoside analog famciclovir reduces HBV replication and transaminase levels in patients with HBV recurrence after liver transplantation and appears to be a promising antiviral strategy in the treatment of HBV in immunocompromised patients.
95
Distribution of activated T cells migrating through the body: a matter of life and death
Jürgen Westermann,Ulrike Bode +1 more
TL;DR: Evidence is provided that preferential survival in the tissue of initial stimulation is the major factor in the preferential distribution of activated T cells.
81
The fate of activated T cells migrating through the body: rescue from apoptosis in the tissue of origin
TL;DR: It is shown that preferential proliferation and reduced apoptosis, rather than preferential immigration, were responsible for the accumulation of activated T cells in the tissue of origin, explaining how immune responses can spread from site to site but still be restricted to certain regions.
59
Long-term outcome of hepatitis C virus infection after liver transplantation
Klaus H.W. Böker,G. Dalley,Matthias J. Bahr,H. Maschek,Hans L. Tillmann,Christian Trautwein,K. Oldhaver,Ulrike Bode,Rudolf Pichlmayr,Michael P. Manns +9 more
TL;DR: Chronic hepatitis develops in the majority of patients with HCV infection after liver transplantation, and the disease course closely resembles that seen in nontransplanted hepatitis C patients.
32